ATE262896T1 - Synergistische zusammensetzungen von lycopin und vitamin e, die der oxidation der ldl verhindern - Google Patents

Synergistische zusammensetzungen von lycopin und vitamin e, die der oxidation der ldl verhindern

Info

Publication number
ATE262896T1
ATE262896T1 AT98928504T AT98928504T ATE262896T1 AT E262896 T1 ATE262896 T1 AT E262896T1 AT 98928504 T AT98928504 T AT 98928504T AT 98928504 T AT98928504 T AT 98928504T AT E262896 T1 ATE262896 T1 AT E262896T1
Authority
AT
Austria
Prior art keywords
vitamin
ldl
oxidation
lycopine
prevent
Prior art date
Application number
AT98928504T
Other languages
English (en)
Inventor
Bianca Fuhrman
Michael Aviram
Zohar Nir
Morris Zelkha
Original Assignee
Lycored Natural Prod Ind Ltd
Bianca Fuhrman
Michael Aviram
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL12111297A external-priority patent/IL121112A/xx
Priority claimed from IL12493098A external-priority patent/IL124930A0/xx
Application filed by Lycored Natural Prod Ind Ltd, Bianca Fuhrman, Michael Aviram filed Critical Lycored Natural Prod Ind Ltd
Application granted granted Critical
Publication of ATE262896T1 publication Critical patent/ATE262896T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
AT98928504T 1997-06-19 1998-06-18 Synergistische zusammensetzungen von lycopin und vitamin e, die der oxidation der ldl verhindern ATE262896T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL12111297A IL121112A (en) 1997-06-19 1997-06-19 Synergistic pharmaceutical or dietary compositionscomprising lycopene and vitamin e for preventing ldl oxidation
IL12493098A IL124930A0 (en) 1998-06-16 1998-06-16 Natural compositions for the prevention of ldl oxidation
PCT/IL1998/000286 WO1998057622A1 (en) 1997-06-19 1998-06-18 Synergistic compositions for lycopene and vitamin e for the prevention of ldl oxidation

Publications (1)

Publication Number Publication Date
ATE262896T1 true ATE262896T1 (de) 2004-04-15

Family

ID=26323453

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98928504T ATE262896T1 (de) 1997-06-19 1998-06-18 Synergistische zusammensetzungen von lycopin und vitamin e, die der oxidation der ldl verhindern

Country Status (8)

Country Link
EP (1) EP0996431B1 (de)
JP (1) JP2002504928A (de)
AT (1) ATE262896T1 (de)
AU (1) AU8031998A (de)
DE (1) DE69822834T2 (de)
DK (1) DK0996431T3 (de)
ES (1) ES2218833T3 (de)
WO (1) WO1998057622A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE322904T1 (de) 2000-05-25 2006-04-15 Boehringer Ingelheim Int Zusammensetzung zum verbesserten zellenschutz welche ein lipophiles antioxydans sowie ein hydrophilen antioxidans enthält
IL141039A (en) 2001-01-23 2006-10-31 Lycored Natural Prod Ind Ltd The composition for the prevention of atherosclerosis containing carotenoids and use for the preparation of drugs to inhibit LDL oxidation
IL141038A (en) * 2001-01-23 2006-10-05 Lycored Natural Prod Ind Ltd Use of carotenoids for the preparation of substances for the treatment of high blood pressure
EP1456670B8 (de) * 2001-08-22 2011-04-27 Cambridge Theranostics Ltd. Verfahren betreffend die behandlung von atherosklerose
US7148028B2 (en) 2001-08-22 2006-12-12 Cambridge Theranostics Ltd. Methods and means relating to atherosclerosis
JP4818637B2 (ja) * 2005-05-02 2011-11-16 日本メナード化粧品株式会社 低密度リポタンパク質（ｌｄｌ）酸化抑制剤
KR101290514B1 (ko) * 2007-10-25 2013-07-26 뉴트리 가부시키가이샤 혈중의 당, 말론디알데히드 수식 ｌｄｌ, 호모시스테인 및/또는 ｃ 반응성 단백질을 저감시키기 위한 조성물
EP2952104A1 (de) 2014-06-05 2015-12-09 Böhm, Kirsten Zusammensetzung und Verfahren zur Vermeidung von Beschädigungen von menschlichen Zellen durch ionisierende Strahlung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2126679C1 (ru) * 1990-10-01 1999-02-27 Бригхэм энд Уименз Хоспитал Способ ингибирования и профилактики возникновения сосудистых явлений бета-каротином и витамином е, фармацевтическая композиция, состоящая из бета-каротина и витамина е, фармацевтическая композиция, состоящая из бета-каротина и аспирина
WO1995035099A1 (en) * 1994-06-20 1995-12-28 Kv Pharmaceutical Company Vitamin/nutrient dosage regimentation
EP0793490A4 (de) * 1994-12-22 1999-12-15 Henkel Corp Zusammensetzungen aus tocopherol und beta-karotin
WO1996019217A1 (en) * 1994-12-22 1996-06-27 Henkel Corporation Pharmaceutical compositions comprising lycopene

Also Published As

Publication number Publication date
WO1998057622A1 (en) 1998-12-23
EP0996431A1 (de) 2000-05-03
ES2218833T3 (es) 2004-11-16
DE69822834D1 (de) 2004-05-06
DK0996431T3 (da) 2004-04-26
EP0996431B1 (de) 2004-03-31
JP2002504928A (ja) 2002-02-12
DE69822834T2 (de) 2005-03-24
AU8031998A (en) 1999-01-04

Similar Documents

Publication Publication Date Title
BR9908222A (pt) Composições para regular a aparência da pele
BG98933A (en) Cooled and atomized nabumetone
TR200101481T2 (tr) Doğal bitkisel zaruri yağlar kullanan kanser tedavi kompozisyonu ve yöntemi.
MX9204268A (es) Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
AU6408298A (en) Essential oil composition
CA2046964A1 (en) Natural antioxidant compositions
ECSP045154A (es) Composiciones de fórmula para infantes que comrende cantidades aumentadas de alfa - lactalbumin
BRPI0108478B8 (pt) composição nutritiva contendo substancias pré-bióticas
BR9915247B1 (pt) compostos biaromáticos análogos da vitamina d, seus usos, composição farmacêutica e composição cosmética contendo os mesmos, e uso da composição cosmética.
WO2002034072A3 (en) Synergistic antioxidant combination of delta tocols and polyphenols
IT8821134A0 (it) Frazioni oligomeriche procianidoliche, loro procedimentodi preparazione e composizioni farmaceutiche che le contengono.
FI896109A0 (fi) Kosmetisk eller farmaceutisk sammansaettning som innehaoller mikrosfaerer av polymerer eller feta substanser fyllda med aotminstone en aktiv produkt.
PT999843E (pt) Composicoes farmaceuticas contendo vitamina d e calcio, sua preparacao e uso terapeutico
ES2188582T3 (es) El uso de ranitidina-citrato de bismuto en combinacion con claritromicina o claritromicina y tetraciclina en la fabricacion de un medicamento para tratar trastornos gastrointestinales.
DE69822834D1 (de) Synergistische zusammensetzungen von lycopin und vitamin e, die der oxidation der ldl verhindern
ES2086771T3 (es) Composicion dermatologica y/o cosmetologica que contiene retinoides.
IT1263840B (it) Formulazioni orali di ubidecarenone in forma di capsule
IL123132A (en) Synergistic composition for preventing ldl oxidation and arresting the progression of atherosclerosis, comprising lycopene and garlic
NZ333966A (en) Use of 1-nonen-3-one as a flavouring agent
DE69531722D1 (de) Karzinostatische Zusammensetzungen, welche Cis-Oxaliplatin und eine oder mehrere andere verträgliche Karzinostatika enthalten
DE69414821D1 (de) Diätetische cholesterinsenkende zubereitungen, die sojaproteine und sitosterine enthalten
MY120958A (en) Use of a flavonoid extract of ginkgo biloba leaves, and more specifically of a terpene-free extract, in the pharmaceutical and/or cosmetic domain and more particularly in the buccodental domain
BR9806193A (pt) Composição bi-aromáticos ligados por um radical heteroetinileno e composições farmacêuticas e cosméticas que os contêm
MD970269A (en) Clavulanates
DE68905973D1 (de) Synergistische suessungsmittel-zusammensetzungen, enthaltend chlorodeoxysucrase, und diese enthaltende zusammensetzungen.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties